Anti-CD20 therapy ameliorates β cell function and rebalances Th17/Treg cells in NOD mice
Sign Up to like & getrecommendations! Published in 2022 at "Endocrine"
DOI: 10.1007/s12020-021-02965-x
Abstract: Anti-CD20 therapy delays type 1 diabetes mellitus (T1DM) progression in both nonobese diabetic (NOD) mice and new-onset patients. The mechanism is not completely defined. This study aimed to investigate the effects of anti-CD20 therapy on… read more here.
Keywords: nod mice; anti cd20; cell function; th17 treg ... See more keywords
2288. Adherence to Hepatitis B Screening and Treatment Guidelines in Oncology Patients Starting Anti-CD20 Therapy
Sign Up to like & getrecommendations! Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy210.1941
Abstract: Abstract Background Hepatitis B virus (HBV) reactivation is a common complication in the treatment of oncology patients when using anti-CD20 monoclonal antibodies (MABs) such as rituximab, obinituzumab, and ofatumumab. In such patients, the reaction of… read more here.
Keywords: antiviral therapy; cd20 therapy; anti cd20; therapy ... See more keywords
Anti‐CD20 therapy for multiple sclerosis‐associated uveitis: A case series
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Neurology"
DOI: 10.1111/ene.15453
Abstract: Approximately 1% of patients with multiple sclerosis (MS) have uveitis, but data on the effects of immunotherapies for MS on MS‐associated uveitis are scarce. The aim of this study was to investigate the ophthalmological outcomes… read more here.
Keywords: cd20 therapy; multiple sclerosis; anti cd20; associated uveitis ... See more keywords